Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 4101-4150 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06811129
Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in Liberia
N/A
Recruiting
410 participants
Started: Oct 28, 2025 · Completed: Nov 1, 2025
2 conditions
1 sponsor
1 location
NCT06654050
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
PHASE2
Not yet recruiting
15 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2027
6 conditions
1 sponsor
1 location
NCT06595940
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
N/A
Recruiting
400 participants
Started: Oct 28, 2025 · Completed: Aug 21, 2034
2 conditions
1 sponsor
1 location
NCT06819176
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People Living With HIV Receiving Antiretroviral Therapy
PHASE1
Recruiting
50 participants
Started: Oct 28, 2025 · Completed: Jan 24, 2029
1 condition
1 sponsor
1 location
NCT06280820
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
N/A
Enrolling by invitation
2,000 participants
Started: Oct 28, 2025 · Completed: Apr 30, 2034
1 condition
1 sponsor
1 location
NCT05663320
A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia
NA
Recruiting
20 participants
Started: Oct 28, 2025 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06507748
A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
NA
Not yet recruiting
70 participants
Started: Oct 28, 2025 · Completed: May 1, 2026
1 condition
1 sponsor
1 location
NCT06066138
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
PHASE1
Recruiting
40 participants
Started: Oct 28, 2025 · Completed: Jan 31, 2027
10 conditions
1 sponsor
1 location
NCT06274749
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
NA
Recruiting
180 participants
Started: Oct 28, 2025 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT05652478
Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers
PHASE2
Recruiting
120 participants
Started: Oct 28, 2025 · Completed: Jan 31, 2030
4 conditions
1 sponsor
1 location
NCT06303193
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
PHASE1/PHASE2
Not yet recruiting
160 participants
Started: Oct 28, 2025 · Completed: Jan 1, 2035
1 condition
1 sponsor
1 location
NCT05713799
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
PHASE2
Not yet recruiting
60 participants
Started: Oct 28, 2025 · Completed: Mar 1, 2026
2 conditions
1 sponsor
1 location
NCT06995885
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
N/A
Enrolling by invitation
30 participants
Started: Oct 28, 2025 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT06995872
Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
PHASE1
Recruiting
34 participants
Started: Oct 28, 2025 · Completed: Jun 1, 2029
1 condition
1 sponsor
1 location
NCT06991751
A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of Central Ohio Health Study to Understand Acculturation as Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating ...
N/A
Not yet recruiting
50 participants
Started: Oct 28, 2025 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT06991738
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
PHASE1/PHASE2
Not yet recruiting
18 participants
Started: Oct 28, 2025 · Completed: Aug 1, 2032
1 condition
1 sponsor
1 location
NCT06998134
Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults
N/A
Recruiting
23 participants
Started: Oct 28, 2025 · Completed: Aug 18, 2028
2 conditions
1 sponsor
1 location
NCT07005297
Clinical Genetics Branch Eligibility Screening Survey
N/A
Not yet recruiting
1,000 participants
Started: Oct 28, 2025 · Completed: Jan 1, 2036
10 conditions
1 sponsor
1 location
NCT07012057
Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis
PHASE2
Not yet recruiting
20 participants
Started: Oct 28, 2025 · Completed: Mar 30, 2029
2 conditions
1 sponsor
1 location
NCT06868914
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)
PHASE1
Recruiting
35 participants
Started: Oct 28, 2025 · Completed: Jan 13, 2028
1 condition
1 sponsor
1 location
NCT07027839
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
PHASE1
Recruiting
30 participants
Started: Oct 28, 2025 · Completed: Feb 22, 2029
1 condition
1 sponsor
1 location
NCT07027826
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
NA
Recruiting
70 participants
Started: Oct 28, 2025 · Completed: Aug 31, 2027
2 conditions
1 sponsor
2 locations
NCT07137455
EDEN Intracardiac Electrogram Recording and Classifying System
NA
Not yet recruiting
50 participants
Started: Oct 28, 2025 · Completed: Nov 1, 2026
1 condition
1 sponsor
1 location
NCT07137442
Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques
N/A
Not yet recruiting
75 participants
Started: Oct 28, 2025 · Completed: Aug 1, 2034
2 conditions
1 sponsor
1 location
NCT06487481
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
PHASE1
Recruiting
32 participants
Started: Oct 28, 2025 · Completed: Dec 1, 2040
5 conditions
1 sponsor
1 location
NCT06876142
Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma
PHASE1/PHASE2
Recruiting
54 participants
Started: Oct 28, 2025 · Completed: Jan 1, 2033
2 conditions
1 sponsor
1 location
NCT07046819
Tirzepatide in MetALD
PHASE2
Not yet recruiting
120 participants
Started: Oct 28, 2025 · Completed: Jul 30, 2026
2 conditions
1 sponsor
1 location
NCT06860607
Environment and Alcohol: A Pilot Study
PHASE1
Recruiting
44 participants
Started: Oct 28, 2025 · Completed: Mar 1, 2028
1 condition
1 sponsor
1 location
NCT04569591
Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s Disease
NA
Not yet recruiting
22 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06707207
Predicting Future Errors During Skill Performance
N/A
Recruiting
40 participants
Started: Oct 28, 2025 · Completed: Oct 1, 2029
1 condition
1 sponsor
1 location
NCT06690294
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
N/A
Not yet recruiting
110 participants
Started: Oct 28, 2025 · Completed: Jan 30, 2026
2 conditions
1 sponsor
1 location
NCT04370795
Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus
PHASE1/PHASE2
Enrolling by invitation
30 participants
Started: Oct 28, 2025 · Completed: Sep 9, 2026
1 condition
1 sponsor
1 location
NCT05621291
A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
NA
Recruiting
60 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2027
2 conditions
1 sponsor
8 locations
NCT07067138
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NA
Not yet recruiting
175 participants
Started: Oct 28, 2025 · Completed: Aug 4, 2029
4 conditions
1 sponsor
1 location
NCT07067151
Using Smartwatches to Monitor Smoking in Real-life Situations
N/A
Enrolling by invitation
30 participants
Started: Oct 28, 2025 · Completed: Mar 20, 2028
1 condition
1 sponsor
1 location
NCT06561828
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
EARLY_PHASE1
Recruiting
600 participants
Started: Oct 28, 2025 · Completed: Nov 2, 2044
1 condition
1 sponsor
1 location
NCT06856226
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
N/A
Recruiting
88 participants
Started: Oct 28, 2025 · Completed: Dec 1, 2028
3 conditions
1 sponsor
1 location
NCT05372627
NHLBI-Emory Advanced Cardiac CT Reconstruction
N/A
Not yet recruiting
1,000 participants
Started: Oct 28, 2025 · Completed: Jan 30, 2031
1 condition
1 sponsor
2 locations
NCT06664814
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
PHASE2
Recruiting
30 participants
Started: Oct 28, 2025 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT07099053
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
N/A
Not yet recruiting
400 participants
Started: Oct 28, 2025 · Completed: Dec 12, 2029
1 condition
1 sponsor
1 location
NCT06904066
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
PHASE1
Recruiting
86 participants
Started: Oct 28, 2025 · Completed: Apr 30, 2029
11 conditions
1 sponsor
1 location
NCT06052631
Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene
N/A
Recruiting
16 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06479824
NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study
NA
Not yet recruiting
60 participants
Started: Oct 28, 2025 · Completed: Sep 1, 2030
1 condition
1 sponsor
4 locations
NCT05722210
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
N/A
Not yet recruiting
500 participants
Started: Oct 28, 2025 · Completed: Jun 30, 2031
1 condition
1 sponsor
1 location
NCT05657405
Observational Study of Advanced Data Analytics in Genetic Conditions
N/A
Recruiting
1,250 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT02522611
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
PHASE1/PHASE2
Not yet recruiting
30 participants
Started: Oct 28, 2025 · Completed: Dec 1, 2026
2 conditions
1 sponsor
1 location
NCT06577454
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
NA
Recruiting
60 participants
Started: Oct 28, 2025 · Completed: Aug 6, 2027
2 conditions
1 sponsor
1 location
NCT07099092
Causal Mechanisms of Odor-Guided Behavior in Humans
EARLY_PHASE1
Not yet recruiting
80 participants
Started: Oct 28, 2025 · Completed: Jul 14, 2035
1 condition
1 sponsor
1 location
NCT06923072
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
PHASE2
Recruiting
12 participants
Started: Oct 28, 2025 · Completed: Dec 15, 2030
4 conditions
1 sponsor
1 location
NCT07137429
Platelet Volunteers, Longitudinal and Multi-omic Study
N/A
Not yet recruiting
400 participants
Started: Oct 28, 2025 · Completed: Sep 15, 2041
1 condition
1 sponsor
1 location
Previous
1
More pages
80
81
82
83
84
85
86
More pages
2369
Next